Mohammad S. Abdelaal

Mohammad S. Abdelaal

Auto-generated profile, based on publicly available information

Mohammad S. Abdelaal

Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Orthopedic Clinics of North America
Verified
Journal Article
Closed access
MAMohammad S. Abdelaal
Mohammad S. Abdelaal
CRCamilo Restrepo
Camilo Restrepo
PSPeter F. Sharkey
Peter F. Sharkey

4 April 2022 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
AHAmer Haffar
Amer Haffar
IKIrfan A. Khan
Irfan A. Khan
MAMohammad S. Abdelaal
Mohammad S. Abdelaal
SBSamik Banerjee
Samik Banerjee
PSPeter F. Sharkey
Peter F. Sharkey
JLJess H. Lonner
Jess H. Lonner

14 March 2023 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
MAMohammad S. Abdelaal
Mohammad S. Abdelaal
BWBright M. Wiafe
Bright M. Wiafe
IKIrfan A. Khan
Irfan A. Khan
JMJustin A. Magnuson
Justin A. Magnuson
ASArjun Saxena
Arjun Saxena
PSPeter F. Sharkey
Peter F. Sharkey

22 July 2022 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
GGGraham S. Goh
Graham S. Goh
NSNoam Shohat
Noam Shohat
MAMohammad S. Abdelaal
Mohammad S. Abdelaal
ISIlan Small
Ilan Small
TTTerence Thomas
Terence Thomas
JPJavad Parvizi
Javad Parvizi
Background: Increased serum glucose variability has been proposed as a risk factor for perioperative morbidity and mortality. Given the greater surgical complexity and complication risk of revision total joint arthroplasty (TJA), previous findings may not be generalizable to the revision population. The purpose of this study was to investigate the association between glucose variability and postoperative complications following aseptic revision TJA. Methods: We identified 1,983 patients who underwent an aseptic revision TJA (636 total knee arthroplasties [TKAs] and 1,347 total hip arthroplasties [THAs]) from 2001 to 2019. Patients with ≥2 postoperative glucose values per day or ≥3 values during hospitalization were included in this study. Glucose variability was assessed using the coefficient of variation (COV). Outcomes included length of hospital stay, 90-day complications, mortality, and periprosthetic joint infection (PJI) as defined by the 2018 International Consensus Meeting criteria. Multivariate regression was used to determine the association between glucose variability and each end point, using COV as continuous and categorical variables (that is, COV tertiles). Results: Patients with high glycemic variability were at 1.7 times greater risk for 90-day complications (odds ratio [OR], 1.664 [95% confidence interval (CI), 1.266 to 2.188]; p < 0.001) and 2 times greater risk for PJI at a minimum 1-year follow-up (OR, 1.984 [95% CI, 1.270 to 3.100]; p = 0.003). The risk of 90-day complications increased by 2.2% (OR, 1.022 [95% CI, 1.012 to 1.032]; p < 0.001) and the risk of PJI increased by 1.8% (OR, 1.018 [95% CI, 1.003 to 1.034]; p = 0.013) for every percentage-point increase in COV. Patients with higher glucose variability also had a longer length of stay (beta, 1.028 days [95% CI, 0.590 to 1.466 days]; p < 0.001). These associations were independent of age, sex, body mass index, Charlson Comorbidity Index, involved joint, operative time, history of diabetes, and mean glucose levels. Conclusions: Higher glucose variability was associated with an increased risk of medical complications and PJI following aseptic revision TJA. Patients undergoing these complex procedures should have glucose levels monitored closely in the perioperative period. Future studies should evaluate the utility of continuous glucose monitoring in this high-risk population. Level of Evidence: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.

7 September 2022 in Journal of the American Academy of Orthopaedic Surgeons
Verified
Journal Article
Closed access
MAMohammad S. Abdelaal
Mohammad S. Abdelaal
ISIlan Small
Ilan Small
MSMatthew B. Sherman
Matthew B. Sherman
PCP. Maxwell Courtney
P. Maxwell Courtney
PSPeter F. Sharkey
Peter F. Sharkey
Background: The severe acute respiratory syndrome coronavirus 2 (COVID-19) pandemic has continued to generate notable disruption in elective total hip arthroplasty (THA) and total knee arthroplasty (TKA). The purpose of this study was to determine whether there is any difference in patient characteristics, revenue, and clinical outcomes in patients undergoing THA and TKA after the start of the pandemic. Methods: We reviewed a consecutive series of 26,493 patients undergoing primary and revision THA and TKA by 48 surgeons in a single arthroplasty practice. We compared demographics, comorbidities, outcomes, and surgeon revenue from THA and TKA procedures from March 2020 to February 2021 with a prepandemic group undergoing a procedure from March 2019 to February 2020. Results: There was a 20% decline in the volume of all cases in the pandemic group (11,688 versus 14,664, P < 0.001). The postpandemic cohort had shorter length of stay (1.58 versus 1.70 days, P = 0.007), had higher rates of home discharge (98% versus 91%, P < 0.001), and were more likely to have their procedure done at an outpatient facility (21% versus 7%, P < 0.001). Even among patients older than 65 years, more pandemic patients underwent a procedure as an outpatient (19% versus 7%, P < 0.001), with no difference in complications or readmissions. Total surgeon charges and payments declined by 17.6% and 16.3%, respectively, during the pandemic (P = 0.010). Conclusion: Although the COVID-19 pandemic resulted in a notable reduction in surgical volume and revenue loss for our practice, we found a marked shift of arthroplasty patients to outpatient facilities with increased rates of home discharge without compromising patient safety.

1 December 2021 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
MAMohammad S. Abdelaal
Mohammad S. Abdelaal
DCDaniel Calem
Daniel Calem
MSMatthew B. Sherman
Matthew B. Sherman
PSPeter F. Sharkey
Peter F. Sharkey